TOKYO, JP & CENTER VALLEY, PA, Dec 4, 2020 - (JCN Newswire) - Olympus Corporation (TSE: 7733) today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. ("VMT")(CEO: Jason Pesterfield), a leading provider of advanced medical devices specializing in interventional pulmonology, for up to USD 340 million. The acquisition will be implemented through Olympus subsidiary Olympus Corporation of the Americas ("OCA"), and will be the latest in a series of strategic acquisitions designed to strengthen Olympus' position as a leading global medical device company.As part of Olympus' Corporate Strategy, unveiled in November 2019, the company vowed to "focus and scale" its therapeutic solutions division. To accelerate the process and provide greater agility, Olympus made OCA the company's therapeutic division headquarters, recognizing the significant growth opportunities in North America. The company also identified three core medical fields to prioritize - gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.According to Nacho Abia, global chief operating officer and CEO of OCA, the VMT acquisition will strategically position Olympus and boost development in other areas, "We are very excited about acquiring VMT because its portfolio of devices will complement our product portfolio and further strengthen our position in respiratory medical devices," he said. "The most significant part of this deal is that we will secure immediate access to VMT's unique Electromagnetic Navigation system with proprietary devices to build a stronger future respiratory product portfolio."Already a leader in bronchoscopy systems, Olympus' endoscope technologies will combine perfectly with VMT's navigation products to develop solutions for improved diagnosis of peripheral lung cancer.Lung cancer affects the highest number of cancer patients and is the leading cause of cancer-related deaths globally.(*) With increased awareness and more lung cancer screenings done by low-dose CT (computed tomography), the need for definitive diagnosis of lesions in the peripheral regions of the lungs by tissue biopsy is expected to increase. Combined with Olympus' technology, VMT's navigational platform and proprietary devices support this need."We are proud to be joining forces with Olympus, a company with a 100-year legacy and a global reputation for quality, leadership and innovation," said Jason Pesterfield, CEO of VMT. "Olympus has a clear strategy to become a global medtech leader, and we're excited to contribute our unique capabilities and become part of this journey."This acquisition will provide immediate incremental revenue and an experienced sales team within the US market. VMT's advanced and proven navigation technology, together with Olympus' respiratory leadership, strengthens and enhances Olympus' global position. For details, please refer to our corporate disclosure, "Notice regarding acquisition of Veran Medical Technologies, Inc. in the United States." (available at: https://www.olympus-global.com/news/ir/2020/)* WHO data: https://www.who.int/news-room/fact-sheets/detail/cancerAbout Veran Medical Technologies, Inc.VMT is a privately held medical device company headquartered in St. Louis, MO. The company's mission is to empower physicians to diagnose cancer earlier and to enable precision therapy to save lives. In the United States, lung cancer kills more people each year than breast, prostate, and colon cancers combined.VMT has developed and commercialized a next-generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System(R). This breakthrough technology has been adopted by leading cancer centers throughout the United States. VMT also provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The combination of these proprietary Always-On Tip Tracked(R) instruments and VMT's exclusive patient respiratory gating technology enables physicians to accurately access lung nodules by accounting for nodule movement during patient breathing, a common challenge for lung specialists. The SPiN Thoracic Navigation System(R) is the first and only technology that enables Pulmonologists or Thoracic Surgeons to accurately access lung nodules outside of an airway using SPiN Perc(R), a navigated transthoracic needle. With SPiN Perc(R), VMT combines endobronchial navigation with percutaneous navigation, allowing physicians to access all lung nodules in a single procedure, regardless of nodule size or location. This eliminates the cost and risk of unnecessary procedures and empowers physicians to provide a same day diagnosis for their patients. About Olympus' Therapeutic Solutions businessIn its Therapeutic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with its early contributions to the development of the polypectomy snare, Olympus' Therapeutic Solutions portfolio has grown to include an array of surgical energy devices and a wide range of instruments to help prevent, detect, and treat disease. For more information, visit www.olympus-global.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 2, 2020 - (JCN Newswire) - The innovative multi-chamber front passenger airbag technology in the all-new 2021 Acura TLX sport sedan has been awarded as a 2020 "Best of What's New" for 2020 by Popular Science and was further distinguished as their "Grand Award" winner among all of the year's automotive entrants. Representing a major leap forward in airbag design, it is the world's first passenger front airbag intended to address the recently recognized issue of severe brain trauma associated with angled frontal collisions. The all-new Acura MDX three-row luxury SUV, set to go on sale early next year, will also feature this award-winning technology as standard equipment.New Acura Airbag Technology wins a Popular Science "Best of What's New" AwardThe new airbag is designed to help reduce head and neck injuries by better controlling the front passenger's head in certain types of crashes. The airbag can better manage lateral collision forces that may cause an occupant's head to rotate severely at high velocity, or to slide off a conventional passenger airbag, increasing the chance of serious injury. Compared to a single inflatable chamber of conventional airbag systems, the new passenger airbag consists of four major components: three inflated compartments (a center chamber and two outward-projecting side chambers that create a wide base across the dash) and an uninflated "sail panel" that stretches between the two side chambers. The "sail panel" is designed to initially catch and decelerate the occupant's head with less force prior to contacting the lower chamber, while directing it inward between the two inflated chambers to cradle and help protect the front seat passenger's head.Co-developed by Honda R&D Americas and safety systems supplier Autoliv, this groundbreaking new airbag design is now being offered to other automakers to enhance the safety performance of their future products.Full details on Acura's next-generation passenger front airbag and other safety innovations, as featured in the all-new 2021 TLX, can be found here: acura.us/safetyinnovation."The 'Best of What's New' awards showcase the year's greatest feats of human ingenuity," says Popular Science Editor-in-Chief Corinne Iozzio. "Even in a year like 2020, innovation has helped us glimpse a future that's safer, smarter, and more enjoyable than we might have thought possible. This collection, which includes everything from a new generation of Mars explorers to ultra-hygienic print-to-order eyeshadows, is full of items we're proud to call the "Best of What's New."Every year, Popular Science reviews thousands of new products and innovations, selecting the top 100 winners across 10 categories. To be selected as a "Best of What's New" winner, a product or technology must represent a significant step forward in its category. Most recently, Acura's True Touchpad Interface, using absolute positioning to deliver a more intuitive and driver-friendly digital experience, was recognized by Popular Science as a "Best of What's New" technology for 2018.About AcuraAcura is a leading automotive nameplate that delivers Precision Crafted Performance -- a commitment to expressive styling, high performance and innovative engineering, all built on a foundation of quality and reliability. The Acura lineup features five distinctive models -- the ILX and TLX sport sedans, the RDX and MDX sport-utility vehicles and the next-generation, electrified NSX supercar. All Acura models sold in North America for the 2021 model year are made in the U.S., using domestic and globally sourced parts.Additional media information including pricing, features & specifications and high-resolution photography is available at AcuraNews.com. Consumer information is available at Acura.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 2, 2020 - (JCN Newswire) - Mitsubishi Heavy Industries Environmental & Chemical Engineering Co., Ltd. (MHIEC), a part of Mitsubishi Heavy Industries (MHI) Group, has formally concluded a contract with the Kashima Regional Administration Association in Ibaraki Prefecture (comprising the cities of Kashima and Kamisu) to design and build a combustible waste management facility planned for construction in Kamisu city. The project to consolidate and replace two existing superannuated facilities was tendered as an open call for proposals, and after review MHIEC was selected to execute engineering, procurement, and construction (EPC) as a single main contractor. The contract is valued at 13,588 million Japanese yen, with completion scheduled for the end of the March 2024.Image perspective of the new plantThe new facility in Towada, Kamisu city will be an energy recovery-type waste management facility equipped with two stoker type incinerators(1), each with waste treatment capacity of 115 tonnes per day (tpd), providing power generating efficiency from the burning of combustible waste of greater than 16.5%. Since the construction site is in an exclusive industrial district surrounded by numerous companies, MHIEC will utilize its accumulated know-how to install compact facilities that effectively utilize the narrow site area in a three-dimensional manner, and take steps to control and prevent noise, vibration, and dust.The Kashima Regional Administration Association was established in 1999 with the addition of responsibility for the administration of refuse-derived fuel (RDF) facilities to the former Municipal Kashima Regional Wholesale Market Association. The Association currently handles the establishment and operation of RDF facilities, construction of combustible municipal solid waste (MSW) facilities, and firefighting services for the cities of Kashima and Kamisu. This new facility will replace the RDF facilities in each of the two municipalities, and allow for integrated incineration of combustible waste, and energy recovery.MHIEC succeeded MHI?s environmental equipment business in 2008, incorporating its accumulated technological development capabilities in environmental systems, and its broad expertise in the construction and operation of waste management facilities both in Japan and overseas. Based on this strong track record, MHIEC is well positioned to provide comprehensive solutions, from plant construction to operation, as well as meet a range of needs including after-sales service and DBO(2) project delivery. Orders for plant retrofit projects have been increasing in recent years.Going forward, MHIEC will build on this record to actively pursue new construction of waste management facilities, as well as enhance the energy efficiency of existing plants, improve incinerator performance through support for remote monitoring and autonomous operation using AI and IoT, and offer solutions to lower lifecycle costs, in order to expand project orders in Japan and overseas.(1) A stoker furnace is the main type of waste-to-energy (WtE) plant. Waste is combusted as it moves along on a fire grate made of heat-resistant castings.(2) Design build operate (DBO) is a project delivery model in which a facility is financed and owned by a local government of other public agency, while a private contractor handles everything from design to operation. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 2, 2020 - (JCN Newswire) - 1. Overview of the programFig. 1 SDGs to be achieved through the programFig. 2 Example of a system to be developed in the social cooperation programFig. 3 Open innovation and conventional research and developmentDENSO Corporation, The Graduate School of Frontier Sciences at The University of Tokyo, NSK Ltd., Bridgestone Corporation, and ROHM Co., Ltd. have jointly established a social cooperation program(1) titled, "Open Innovation of Mobility Technologies to Achieve the SDGs" (Fig. 1). "SDGs" refers to the 17 sustainable development goals set by the United Nations in 2015, which call for urgent action in creating a more livable and equitable world. The program will run from December 1, 2020, to March 31, 2024, and be organized by two researchers, including Hiroshi Fujimoto, Associate Professor of the Graduate School of Frontier Sciences. It will conduct R&D on technologies for the electrification of mobility and making it more resource-efficient and sustainable. It will also test a mechanism for making part of the results publicly available to support open innovation.2. Details of research under the programResearch themeMobility is made possible by harnessing knowledge in various fields, such as electrical engineering, electronic engineering, mechanical engineering, and materials science and engineering. Under the program, research on mobility will be jointly conducted across multiple scientific fields with the four companies instead of focusing on conventional problem-solving in a single scientific field. Specifically, the main research theme will be dynamic wireless power transfer (DWPT) systems and vehicle dynamics controls, which will be developed based on research under the JST Mirai-Program, as well as systems that combine these technologies (Fig. 2).Open innovationPractical application of research on DWPT systems requires not only the development of on-board components but also extensive research encompassing power feeding equipment and control systems. Participants in the research and development will be actively invited to conduct research within or outside the scope of the program. Research through open innovation will be promoted to build the foundation for technology innovation. The framework and regulations for open innovation involve uncertainties, so a model of successful open innovation will be established (Fig. 3).3. Future outlookThe program will create new mobility technologies, including a new DWPT system developed from the third-generation DWPT in-wheel motors. The aim is to move to the field operational test phase in 2025 and beyond, toward the practical application of the systems and control technologies proposed by the program.(1) A program that is established at education and research institutes, such as faculties and graduate schools, by using expenses received from external organizations (excluding national research and development agencies), such as private companies, for conducting research on common issues with high public interest. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 2, 2020 - (JCN Newswire) - Mitsubishi Heavy Industries Air-Conditioning and Refrigeration Corporation (MHI-AC&R), a Group company of Mitsubishi Heavy Industries, Ltd. (MHI), has developed a large-capacity 80 horsepower (HP) model to add to its series of "C-puzzle" fluorocarbon-free commercial refrigeration condensing units that use R744, a natural refrigerant of carbon dioxide (CO2). The new model responds to increasing demand for larger-capacity refrigeration system that use natural refrigerants, especially for food refrigeration applications such as cold storage facilities. The new 80HP model C-puzzle realizes environmental load reduction initiatives through energy saving and using the natural refrigerant. It is scheduled to go on sale in the domestic market in summer 2021.Refrigeration condensing unit (80HP model)The 80HP model C-puzzle will complement the 10HP model (HCCV1001) and 20HP model (HCCV2001M) launched since 2017 and the 40HP model added to the C-puzzle series in 2020. Introduction of the 80HP model will not only respond to rising demand for larger-capacity refrigeration systems, but also expand the range of applications beyond refrigerated storage to further include food freezing and ice making.As with earlier models in the C-puzzle series, the new 80HP model is equipped with a proprietary two-stage compressor integrating a scroll compressor and a rotary compressor developed and manufactured by MHI Thermal Systems(1). The scroll compressor delivers superlative efficiency under heavy loads, while the rotary compressor offers outstanding efficiency with lighter loads. Together, they result in higher efficiency and noise reduction through the entire operating range. In addition, integrated compact design of the gas cooler and the compressor unit helps to reduce plumbing, thus making the new unit suitable to diverse locations.The refrigerant used in the C-puzzle is R744, a natural refrigerant of carbon dioxide (CO2) and an ozone depletion potential (ODP) of its refrigerant is zero and global warming potential (GWP) is only 1. As a result, the environmental impact is very low, making a significant contribution to the prevention of global warning. In Japan, low-GWP refrigeration systems are mandated under the Act on Rational Use and Proper Management of Fluorocarbons enacted in April 2015. Globally, with effectuation in January 2019 of the Kigali Amendment to the Montreal Protocol on Substances that Deplete the Ozone Layer(2), coupled with enactment of the Revised Ozone Layer Protection Law, phasing down of production and usage of hydrofluorocarbons (HFCs) is now mandatory, part of intensifying moves to prevent climate change.Today the adoption of natural refrigerants in the refrigeration and food freezing markets lags at around 30%, and in response moves are accelerating toward adopting natural refrigerants in the domestic market for low-temperature systems. Business expansion is anticipated from growing demand for use not only in new systems but also for upgrades of existing units currently using fluorocarbon refrigerants.Going forward, MHI-AC&R will continue to focus on expanding and improving its offerings of energy saving products that use low-GWP refrigerants, as its way of promoting adoption of natural refrigerants in the refrigeration market and thereby contributing to protection of the global environment.(1) MHI Thermal Systems' two-stage compressor adopts the world's first technologies (patented) enabling outstanding efficiency even with high-pressure refrigerants.(2) Formally known as the "Act on Rational Use and Proper Management of Fluorocarbons," this is a totally revised update, carried out in April 2015, to the original Fluorocarbons Recovery and Destruction Law enacted in 2001. Under this new legislation, commercial refrigeration condensing units and stationary refrigeration units with a refrigeration capacity exceeding 1.5 kilowatt (kW) (approx. 2HP) are required by 2025 to adopt refrigerants with a GWP below 1500 (CO2=1). Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 2, 2020 - (JCN Newswire) - MITSUBISHI MOTORS CORPORATION (MMC) launched its flagship plug-in hybrid SUV, the OUTLANDER PHEV at the 37th Thailand International Motor Expo 2020(1) and started taking orders. Following the launch in Indonesia and the Philippines, Thailand is the third country in the ASEAN region to introduce the model."As announced in the new Environmental Plan, we aim to raise the proportion of electric vehicles to 50 percent in the total sales by 2030 to contribute to the development of a sustainable society," said Takao Kato, chief executive officer of MMC. "The introduction of the OUTLANDER PHEV in Thailand aligns with our initiative to promote an electrified future. It marks a key milestone for electromobility to the customers in Thailand who are seeking for an environmentally-friendly solution."The OUTLANDER PHEV is an embodiment of MITSUBISHI MOTORS' expertise in electrification, SUV and all-wheel control technologies. The twin-motor 4WD combined with S-AWC (Super All Wheel Control) system delivers a quiet, smooth yet powerful acceleration unique to electric vehicles, enabling anyone to enjoy handling with peace of mind. With global cumulative sales volume reaching more than 260,000 units(2) since the launch in 2013, the OUTLANDER PHEV is the world's best-selling PHEV(3) and has been Europe's best-selling PHEV for five consecutive years (2015-2019)(4). With this success, MMC expands the global PHEV lineup with the addition of the new ECLIPSE CROSS which will be launched in Japan in early December.Mitsubishi Motors (Thailand) Co., Ltd. (MMTh), MMC's local producer and distributor, will also showcase the DENDO DRIVE HOUSE (DDH) at the event. DDH is a packaged system comprising the EV/PHEV, a bi-directional charger, solar panels and home battery, and is designed for home use. The customer can charge their EV/PHEV at home using solar-generated power and can conversely supply electricity back to their home, allowing them to save electricity costs and secure emergency power supply.MMTh signed the Memorandum of Understanding (MoU) with Electricity Generating Authority of Thailand (EGAT) in October to collaborate on the development, testing and data collection of energy conversion from Vehicle to X (V2X)5 by using the OUTLANDER PHEV. MMTh and EGAT will work together to study the V2X business in Thailand.(1) December 1 is VIP and press preview day, December 2 is the opening ceremony and Grand Charity Day, and the show is open to the public from December 3 to 13. For precaution measures against COVID-19, please see the official website at the following link (in Thai):https://www.motorexpo.co.th/(2) As of October 2020(3) Source: MITSUBISHI MOTORS' internal sales data from January 2013 to September 2020(4) Source: MITSUBISHI MOTORS' internal sales data from January 2015 to December 2019(5) A general term encompassing Vehicle to Home (V2H) and Vehicle to Grid (V2G), among othersAbout Mitsubishi MotorsMITSUBISHI MOTORS CORPORATION is a global automobile company based in Tokyo, Japan, which has a competitive edge in SUVs and pickup trucks, electric and plug-in hybrid electric vehicles. Since the Mitsubishi group produced its first car more than a century ago, we have demonstrated an ambitious and often disruptive approach, developing new vehicle genres and pioneering cutting-edge technologies. Deeply rooted in MITSUBISHI MOTORS' DNA, our brand strategy will appeal to ambitious drivers, willing to challenge conventional wisdom and ready to embrace change. Consistent with this mindset, MITSUBISHI MOTORS introduced its new brand strategy in 2017, expressed in its "Drive your Ambition" tagline - a combination of personal drive and forward attitude, and a reflection of the constant dialogue between the brand and its customers. Today MITSUBISHI MOTORS is committed to continuous investment in innovative new technologies, attractive design and product development, bringing exciting and authentic new vehicles to customers around the world. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 2, 2020 - (JCN Newswire) - NEC Corporation (TSE: 6701) announced today that Lufthansa Airlines and Swiss International Airlines (SWISS), Lufthansa Group airline members of Star Alliance, launched the "Star Alliance Biometrics" identity verification platform utilizing NEC's facial recognition technologies at Frankfurt Airport and Munich Airport. NEC and Star Alliance have been cooperating since July 2019 in the development of an identity verification platform utilizing biometric certification(1), and this launch at Frankfurt Airport and Munich Airport is the first commercial service to emerge from the partnership. Passengers using this service can pass through security access and boarding gates without contact by registering face images and passport information with mobile apps from each company in advance. This platform features NEC's facial recognition engine, which has been evaluated as the world's most accurate(2), in order to ensure high-precision certification, even when individuals are wearing masks. With the worldwide spread of COVID-19, NEC aims to contribute to safer and more secure air travel by helping to control the spread of illness by enabling non-contact, mask-worn check-in airport boarding procedures. This service is available to Lufthansa and SWISS Miles & More frequent flyer program members who agree to and register for the use of biometric information. Facial images and personal information of passengers are encoded and safely stored on the platform, which is designed in accordance with the laws and regulations of information protection in each country that it operates, and customer names are not saved. Moreover, Star Alliance will not use personal information without the consent of passengers. Over 1,700 Miles & More members have already registered for the new service, with processing efficiency measurements now underway. NEC's facial recognition is part of the NEC I:Delight(3) platform of contactless biometric solutions that make touchpoints touchless. Going forward, NEC aims to strengthen biometric collaboration with Star Alliance, while expanding personalized services both inside and outside the airport in order to make the travel experience more enjoyable.(1) STAR ALLIANCE AND NEC CORPORATION SIGN PARTNERSHIP AGREEMENT TO ENHANCE PASSENGER EXPERIENCE THROUGH BIOMETRIC DATA RECOGNITION TECHNOLOGYhttps://www.nec.com/en/press/201907/global_20190726_01.html(2) NEC Face Recognition Technology Ranks First in NIST Accuracy Testinghttps://www.nec.com/en/press/201910/global_20191003_01.html(3) NEC I:Delighthttps://www.nec.com/en/global/delight/About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 2, 2020 - (JCN Newswire) - NanoBridge Semiconductor, Inc. (NBS), which designs and manufactures advanced circuits and conducts IP-licensing sales using NanoBridge(1), a resistance-change switching technology for semiconductors, today announced that it has issued series A preferred stock to Japan Industrial Partners, Inc., NEC Corporation (TSE: 6701), and other companies to raise approximately 130 million yen.NBS is a venture company established by NEC researchers in September 2019. NanoBridge is a technology to control the creation or destruction of nanometer sized metal bridges in a solid electrolyte through the application of voltage, thereby realizing on and off-switch status. It is attracting attention as an ideal technology for FPGA(2) and memories that can repeatedly rewrite circuits. This is because NanoBridge consumes less power, as it does not require power to maintain an on or off status, and is highly resistant to both radiation and extreme temperatures. NEC has an established history of promoting the commercialization of NanoBridge, and decided to transfer NanoBridge-related intellectual property to NBS and conduct a spin-off in order to further drive the growth of this business. Through this fundraising, NBS will demonstrate its technologies in areas where radiation resistance is essential, such as aerospace and communications infrastructure. At the same time, NBS will develop a broad range of NanoBridge businesses for domestic and international manufacturers, such as IoT device and automobile manufacturers, while aiming to achieve sales of 5 billion yen in 2025. "The discovery of the atomic switch, based on the movement of atoms rather than electrons, was a major breakthrough in basic science," said Richard E. Dyck, Director, Japan Industrial Partners, Inc. "The team at NanoBridge, after two decades of skilled and focused engineering, has transformed this breakthrough into the realm of practical application. It is exciting to see the NanoBridge atomic switch can now be manufactured economically and in volume, on standard production equipment.""Under the Mid-term Management Plan 2020, NEC is strengthening its business development capabilities and commercializing competitive technologies," said Osamu Fujikawa, Senior Vice President, NEC Corporation. "We have invested in NBS to support the enthusiasm of our researchers for taking on new challenges and driving the advancement of outstanding NEC technologies into the worldwide marketplace."(1) NanoBridge(R) is a resistance-change type switch developed by NEC together with the National Institute for Materials Science. By controlling the creation or destruction of bridges formed by metal atoms in a solid electrolyte through the application of voltage, its resistance changes significantly, functioning as a wiring switch. The switch's resistance value is maintained even when the power supply is turned off, giving it non-volatility. Circuit non-volatility is an effective way to achieve reduced power consumption in ICT devices and systems. NanoBridge(R) is a registered trademark of NEC.(2) Field Programmable Gate Array. Logic LSI design technology for rewritable field programmable gate arrays.About NanoBridge Semiconductor, Inc.NanoBridge Semiconductor, Inc. (NBS) was established in 2019 in Tsukuba, Japan, to "Deliver ICT applications everywhere with Nanobridge technology." NBS provides low-power and rad-hard programmable AIoT terminals and nonvolatile memory through NanoBridge. At NBS, customers come first. NBS strives to build deep relationships with customers and works together for opening up a New Normal Society. For more information, visit NBS at new windowhttps://nanobridgesemi.com/. About Japan Industrial Partners, Inc.Japan Industrial Partners (JIP) is a private equity fund management company established in 2002. JIP has strong track records in supporting strategic carve-outs that realize growth potential and encourage autonomous growth. JIP's main philosophy in investing in Japanese companies is to realize continuous growth of the business by bringing better products and services to the users and customers and by creating a productive and rewarding work place for its employees. About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 1, 2020 - (JCN Newswire) - TRENDE Inc., a renewable energy retailer in Japan, has been selected to join 11 other ground breaking growth stage ventures at the 2020 Unreasonable Impact Asia Pacific program.With the global pandemic continuing to have an enormous impact on all aspects of life, including the global workforce, migration, and the environment, supporting entrepreneurial solutions addressing these challenges is critical. Unreasonable Impact, a unique partnership between Barclays and Unreasonable Group is focused on supporting and scaling up high-growth ventures within the green economy, ensuring that their impactful solutions reach new markets, transform even more lives and create thousands more jobs in the process.After a rigorous selection process involving hundreds of world-class companies, Jeffrey Char, TRENDE's co-founder and Chairman, has been invited to join 11 other leading entrepreneurs from across Asia Pacific for the first ever virtual iteration of the Unreasonable Impact Asia Pacific program, which aims to accelerate the growth of their companies.Impacting the future of food, energy, sustainable living and supply chains, each entrepreneur is selected to participate based on their potential to address key social and environmental issues and to create at least 500 jobs within the next five years.The program connects the entrepreneurs to a global community of power-house mentors and industry specialists, including experts from across Barclays through tried and tested methodologies and approaches."We founded TRENDE as a response to the climate crisis and the Japan's heavy reliance on fossil fuels. Our mission is to accelerate the widespread adoption of renewable energy and redefine the energy ecosystem in Japan," said Char. "We are excited to join the Unreasonable Impact Asia Pacific program and leverage their community to amplify our positive impact."Lars Aagaard, Head of M&A and Head of Financial Sponsors, Asia Pacific at Barclays, said, "We are delighted to welcome the latest cohort of ventures onto our first virtual Unreasonable Impact program here in Asia Pacific. Tackling some of today's greatest challenges, the entrepreneurs are developing groundbreaking solutions and, in partnership with Unreasonable Group, we look forward to supporting them on their journey to scale."Daniel Epstein, Founder and CEO of Unreasonable Group, added, "We are committed to the idea that doing well and doing good are not mutually exclusive and Unreasonable Impact's success to date demonstrates the growing appetite for purpose and profit driven businesses. Our now highly curated virtual programs provide a space to share wisdom, build a lasting community of support and deep dive into critical conversations, empowering our entrepreneurs towards transformative impact and growth. We are so excited to welcome TRENDE into our global community and look forward to supporting Jeffrey Char along with our partners Barclays, to scale and in the process accelerate the creation of thousands of new jobs."Cumulatively, the twelve ventures have generated more than USD $76.28 million in revenue, raised USD $114.48 million in funding and are operating in 26 countries.To date, the ventures that comprise the Unreasonable Impact community have positively impacted more than 220 million people, reduced greenhouse gas emissions by 55 million tons, and generated more than 37,000 net new jobs. The companies have also raised more than USD $3 billion in funding. TRENDE joins this notable global network in its shared effort to create thousands of jobs on the frontier of the green economy. For more information, visit www.unreasonableimpact.comThe participating companies include:- Canopy Power: Deploying reliable, renewable electricity supply for remote businesses and communities across Asia Pacific. https://www.canopypower.com/- DeHaat: Building AI-enabled technologies to revolutionize supply chain and production efficiency in the farm sector. https://agrevolution.in/- Frontier Markets: Alleviating poverty by investing in rural households, and especially women. https://frontiermkts.com/- gFlow+: Providing electric, solid-state water meters and smart metering solutions for a more water-efficient future. http://www.gflowplus.com/- Jumbotail: Organizing the food and grocery ecosystem in India using technology, data science, and design. https://jumbotail.com/- Maeko: Turning organic waste into fertilizer in just 24 hours with cutting-edge compost machines. https://www.maeko.com.my/- Mobi-Air: Delivering breakthrough low-energy, low-cost, competitive air filtration technology. https://mobiair.technology/- MOVUS: Delivering an all-in-one equipment monitoring solution for smarter and more efficient machinery. https://www.movus.com.au/- Shiok Meats: Transforming the food industry in Asia with cell-based, clean meat and seafood. https://shiokmeats.com/- TRENDE: Providing Japan affordable, renewable, and local energy through rooftop solar. https://trende.jp/- Tridi Oasis Group: Recycling locally-sourced plastic waste into high quality raw materials. https://www.tridi-oasis.com/- TurtleTree Labs: Recreating the full composition, functionality and taste of milk using the latest cutting-edge innovation in biotech. https://turtletreelabs.com/About TRENDETRENDE Inc. is an online renewable energy retailer selling electricity to residential customers in Japan via its Hot Denki (https://hotdenki.jp) and Ashita Denki (https://ashita-denki.jp/) service websites. TRENDE's mission is to accelerate the widespread adoption of renewable energy and redefine the energy ecosystem in Japan with a customer-centric business model and innovative P2P platform. The company's investors include Tokyo Electric Power, Itochu, Idemitsu and Dubai Electricity and Water Authority. For more information, please visit http://trende.jp/.About Unreasonable Impact, created with BarclaysUnreasonable Impact is an innovative multi-year multi-geographic partnership between Barclays and Unreasonable Group to launch the world's first global network focused on scaling up entrepreneurial solutions that will help employ thousands worldwide in the emerging green economy. To date, the more than 150 ventures that comprise the global cohort operate in more than 180 countries, have raised over $3bn USD in funding, have generated over $2.8bn USD in revenue, and have created more than 37,000 net new jobs since joining Unreasonable Impact. For more information, please visit www.unreasonableimpact.comAbout BarclaysBarclays is a British universal bank. We are diversified by business, by different types of customer and client, and by geography. Our businesses include consumer banking and payments operations around the world, as well as a top tier, full service, global corporate and investment bank. Our purpose is creating opportunities to rise. For over 325 years we have funded progress, and today we remain committed to helping make our world more sustainable, more inclusive and more connected. For further information about Barclays, please visit www.home.barclays.Barclays in Asia PacificBarclays has been in Asia Pacific for over 50 years and primarily supports corporations and financial institutions across the Asia region, catering to their cross-border Corporate and Investment banking needs and connecting them to the capital markets of Europe and the Americas. In Asia Pacific, Barclays International has a presence in Hong Kong/ mainland China, Japan, Singapore, India and Australia.About Unreasonable GroupBringing together a global network of entrepreneurs, investors, creatives and business leaders, Unreasonable acts as a catalytic platform for entrepreneurs tackling some of the world's most pressing challenges facing us today. From designing highly curated immersive programs, facilitating access to a global network of mentors to operating a private equity fund and providing advanced storytelling and media activities, Unreasonable operates at the highest intersection of business and impact. It is uniquely positioned to support growth stage entrepreneurs solving key global environment and social challenges to scale up through the deployment of knowledge, networks and capital. For more information about Unreasonable, please visit www.unreasonablegroup.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Dec 1, 2020 - (JCN Newswire) - Fujitsu today announced that its O-RAN compatible 5G Radio Unit was selected by KDDI Corporation for the construction of virtualized base station(1) for 5G commercial services in Japan, planned delivery in the second half of FY2021.Fig. Conceptualization of Virtualized Base Station ConfigurationFeatures of the Radio UnitThe newly developed 5G Radio Unit uses O-RAN(2) standard specifications for fronthaul interface for communication with base station controllers (CU: Central Unit/DU: Distributed Unit). This makes it possible to establish a flexible network with an O-RAN configuration by connecting base station controllers between different vendors that comply with this specification. Aiming to accelerate the delivery of 5G services, Fujitsu will make miniaturization and low power consumption a reality for Radio Units that utilize highly-efficient, wide-band power amplification technology. Mounting more antenna elements than conventional MIMO (Multi Input Multi Output(3)) technologies enhance the effects of beamforming(4) and spatial multiplexing and will ultimately help to deliver seamless, speedy mobile communications for users in places where many people gather.Future DevelopmentsIn the future, Fujitsu will continue its contributions to the global development of O-RAN and support the development of KDDI's advanced 5G commercial services, delivering leading-edge Radio Units that draw on wireless technologies and expertise cultivated over many years. Through these initiatives, Fujitsu will play a key role in fulfilling real-world communication requirements in a variety of use case scenarios, including smart factories utilizing 5G and autonomous driving.Comments from Toshikazu Yokai, Executive Officer, KDDI Corporation"KDDI aims to provide flexible end-to-end network slicing services with 5G network. We expect that Fujitsu's Radio Unit that is O-RAN (Open Interfaces) compliant will contribute significantly to the realization of this plan. As a "company contributing to the sustainable growth of society", KDDI will contribute to increased sophistication in the industry and create new social value through the provision of even more easy to use and highly reliable communication services."(1) Virtualized Base Station base station equipped with software having base station control function in general purpose server.(2) O-RAN A common specification developed by the O-RAN Alliance (Open Radio Access Network Alliance), an industry group that promotes standardization with the aim of realizing a next-generation radio access network that is open and expandable, including 5G.(3) MIMO A technology that enables high-speed communication by simultaneously transmitting different signals from multiple transmitters and separating the signals received by multiple receivers.(4) Beamforming A technique for concentrating radio waves in a specific direction by controlling the phase (angle) of a signal emitted by an antenna element on an antenna panel.About Fujitsu LtdFujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 130,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.9 trillion yen (US$35 billion) for the fiscal year ended March 31, 2020. For more information, please see www.fujitsu.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

Tokyo and London, Dec 1, 2020 - (JCN Newswire) - The UK Government and NEC Corporation today announced the launch of the NEC "NeutrORAN" project, which will showcase the latest innovations in the Open Radio Access Network (RAN) space.The project will be used to test and demonstrate a multiple operator, neutral host solution using an Open RAN ecosystem. NEC considers the planned architecture to be scalable and to have potential on a global scale beyond the UK. The project objectives are to reduce costs and drive efficiencies enabling rural communities and businesses to prosper by removing the digital divides that still exist in the UK and the rest of the world.This pioneering project will see 5G Open RAN live within the UK in 2021, testing solutions to deploy 5G networks in cost effective, innovative and secure ways.NEC is leading the drive on open standards with the establishment of a Global Open RAN Center of Excellence in the UK. The NeutrORAN will be one of the first solutions delivered by the Center of Excellence."I am delighted to welcome NEC to Wales for this innovative trial. It will help give mobile companies greater choice and flexibility in how they build their networks so we can diversify the global telecoms supply chain."The project is another step in NEC's growing commitment to the UK and follows the establishment of the company's Global Open RAN Center of Excellence in the UK," said Oliver Dowden, UK Government Digital Secretary."We see this project as a catalyst for NEC introducing Open RAN into the UK and enabling the acceleration of 5G deployment,"said Chris Jackson, CEO of NEC Europe Ltd.About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Nov 30, 2020 - (JCN Newswire) - Showa Denko (SDK; TSE:4004) decided at its Board of Directors meeting today on changes in corporate management (directors, corporate officers and councilors).Hisashi Maruyama (President and CEO, Showa Denko Materials Co., Ltd.) will be elected Director of SDK at the General Meeting of Shareholders in late March 2021.Koichi Nishimura (Assistant to President for promotion of chemicals safety and environmental protection; officer in charge of Industrial Gases, Basic Chemicals, Electronic Chemicals, and Functional Chemicals divisions as well as Kawasaki, Higashinagahara, Isesaki and Tatsuno plants) will resign as Corporate Officer on January 3, 2021. He will assume the post of President, Union Showa K.K., on January 4.Akihiro Jimbo (General Manager, Basic Chemicals Division) will also resign as Corporate Officer on January 3. He will become business adviser to Maruzen Showa Unyu Co., Ltd. effective January 4.Meanwhile, Katsuyuki Tsuji (Associate Councilor; General Manager, Advanced Battery Materials Division; President, Showa Denko Packaging Co., Ltd.) will be newly appointed Corporate Officer on January 4.There will be the following changes in corporate officers' responsibilities as from January 4:Jiro Ishikawa (Senior Managing Corporate Officer, General Manager, Device Solutions Division; officer in charge of Electronics Materials Division and Chichibu Plant) will oversee Electronics Materials Project (instead of Electronics Materials Division).Keiichi Kamiguchi will be promoted to Managing Corporate Officer. He will continue working as Chief Risk Management Officer; officer in charge of Internal Audit, Legal, CSR & General Affairs, Human Resources, and Purchasing & SCM departments; and Chairman, Security Export Control Committee.Masunori Kaiho (officer in charge of Production Technology, Energy & Electricity, SPS Innovation and Responsible Care departments; and Chairman, Safety Measures Committee) will additionally oversee Kawasaki, Higashinagahara, Isesaki and Tatsuno plants. Hiroshi Sakai (Chief Technology Officer; officer in charge of Advanced Battery Materials Division, Institute for Integrated Product Development, Advanced Technology Laboratory, and Corporate R&D and Intellectual Property departments) will cease to oversee Advanced Technology Laboratory.Kazuo Hirakura (General Manager, Industrial Gases Division; President, Showa Denko Gas Products Co., Ltd.) will additionally take charge of Basic Chemicals, Electronic Chemicals and Functional Chemicals divisions.Meanwhile, Nobuhiro Kato (General Manager, IR Office, Finance & Accounting Department), Takanori Hieda (General Manager, Responsible Care Department), and Takayuki Tohaya (Corporate Strategy Department) will resign as Councilors on January 3. Kato will serve as Corporate Expert, Finance & Accounting Department, as from January 4. Hieda will be appointed President of Tsurusaki Kyodo Doryoku K.K., and Tohaya as President of Showa Denko Kenzai K.K., both effective January 4.Effective January 4, Makoto Kimura (General Manager, Environment, Safety & Quality Assurance Control Department, Oita Complex), Hiroyoshi Hayami (Associate Councilor; General Manager, Internal Audit Department), Kiyofumi Matsuoka (Associate Councilor; General Manager, Aluminum Specialty Components Division), and Satoshi Hara (Associate Councilor; General Manager, Purchasing & SCM Department) will be newly appointed Councilors. Kimura will become General Manager, Responsible Care Department as well as its Environment & Safety Office. Hara will become General Manager, Basic Chemicals Division.Tamami Koyama (Councilor; General Manager, Advanced Technology Laboratory) will become Councilor, Assistant to President, effective January 4.As of late March next year, the Board of Directors will consist of Kohei Morikawa (Representative Director; President and CEO); Hidehito Takahashi (Representative Director; CSO), Motohiro Takeuchi (Representative Director, CFO), Hideo Ichikawa (Director; Chairman of the Board), Hisashi Maruyama (Director; President, Showa Denko Materials), and Hiroshi Sakai (Director; CTO); as well as Masaharu Oshima, Kiyoshi Nishioka, Kozo Isshiki, and Noriko Morikawa (Outside Directors). In addition, Toshiharu Kato and Jun Tanaka will serve as Audit & Supervisory Board Members, and Kiyomi Saito, Setsu Onishi, and Masako Yajima as Outside Members of the Audit & Supervisory Board. About Showa Denko K.K.Showa Denko K.K. (SDK; TSE:4004, ADR:SHWDY) is a major manufacturer of chemical products serving from heavy industry to computers and electronics. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial, high-performance and high-purity gases and chemicals for semicon and other industries, the Inorganics Sector provides ceramic products, such as alumina, abrasives, refractory/graphite electrodes and fine carbon products. The Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high bright LEDs, and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, please visit www.sdk.co.jp/english/.Contact:Showa Denko K.K., CSR & Corporate Communication Office, Tel: 81-3-5470-3235 Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Nov 30, 2020 - (JCN Newswire) - Mitsubishi Heavy Industries, Ltd. (MHI) has completed a capital investment in Monolith Materials, Inc. (Monolith), a U.S. company with innovative technology enabling the production of hydrogen and carbon black from methane, which is abundant in natural gas, by the process of methane pyrolysis. The investment has been executed through Mitsubishi Heavy Industries America, Inc., MHI's base of regional operations in the U.S. Monolith Materials is the first U.S. manufacturer to produce a clean, industry-transforming hydrogen known as "turquoise hydrogen"(1) on a commercial scale.By investing in Monolith, MHI Group looks to strengthen and diversify its hydrogen value chain - one of the key factors needed to reduce environmental impact and ensure the energy transition's success - through technologies that can produce turquoise hydrogen, which does not emit CO2 in its production process, as well as high-purity carbon black. Specifically, this investment advances the production and supply of hydrogen through plasma-based methane pyrolysis technology, which uses renewable energy as its heat source."As the importance of hydrogen to realizing a decarbonized society gains popularity, especially in Europe, the United States, and Japan, various clean hydrogen production technologies and supporting processes are required to make that vision a reality. Such technologies include the production of turquoise hydrogen derived by thermal decomposition of methane contained in natural gas, along with production of green hydrogen produced by water electrolysis technology using renewable energy, blue hydrogen derived from fossil fuels that do not emit CO2 and the supporting function of CCUS (carbon capture, utilization and storage). MHI Group is taking a proactive approach to creating and investing in technologies to meet this global demand."By solving the century-old problem of scaling methane pyrolysis to a commercial level, Monolith Materials has emerged as a leader in the manufacturing of emissions-free hydrogen," said Yoshihiro Shiraiwa, president and CEO of Mitsubishi Heavy Industries America, Inc. "While we're evaluating a number of clean-energy development options, Monolith offers great promise. We're excited to be the first in a new wave of strategic investors supporting the development of their technology.""Successfully scaling Monolith's technology to serve a global marketplace will benefit from the kind of investment that we have from Mitsubishi Heavy Industries," said Rob Hanson, co-founder and CEO of Monolith Materials. "This relationship will be a model for evaluating future investment opportunities to make emissions-free hydrogen the standard around the world."Monolith Materials, which was founded in 2012, developed a process technology that converts natural gas into clean hydrogen and a solid carbon material called carbon black, a critical raw material in the automotive and industrial sectors. The company is currently in the operating stage of Olive Creek 1 (OC1), its first commercial-scale emissions-free production facility designed to produce approximately 14,000 metric tons of carbon black annually along with clean hydrogen. In addition to producing carbon black and clean hydrogen, the company recently announced its plans to produce emissions-free ammonia at a second phase production facility known as Olive Creek 2 (OC2) in Hallam, Nebraska.Combined, Monolith Materials' production of turquoise hydrogen, emissions-free ammonia and carbon black are expected to reduce greenhouse gas emissions by as much as 1 million metric tons per year compared to traditional manufacturing processes.Through its capital investment in Monolith, MHI Group will enter the field of hydrogen production and supply supporting that company's pyrolysis technology which enables use of renewable energy as the heat source. MHI will explore technological innovations to promote decarbonization throughout the industrial sector, using the produced hydrogen not only in power generation systems, but also in fertilizer production facilities, steelworks, etc.Going forward, MHI will continue taking steps to contribute to the achievement of a decarbonized society and society's sustainable development, and through such activities it will proactively pursue its corporate growth.(1) To facilitate identification of the level of hydrogen's impact on the environment, it is becoming increasingly common around the world to denote the degree of environmental impact, such as CO2 emissions, in its production process using a color image. Green, turquoise, and blue are considered clean hydrogen.About Monolith MaterialsMonolith Materials is a next‐generation chemical and hydrogen company that uses renewable electricity as part of a proprietary process to convert conventional and renewable natural gas to carbon black and hydrogen in an environmentally advantaged manner. Monolith is backed by Azimuth Capital Management, Cornell Capital LLC, Imperative Ventures and Warburg Pincus. For more information on Monolith Materials visit www.monolithmaterials.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Nov 30, 2020 - (JCN Newswire) - Eisai Co., Ltd. and Wren Therapeutics Ltd. today announced that the companies have entered into an exclusive research collaboration agreement aiming to advance the discovery of novel small molecules that target alpha-synuclein for the potential treatment of synucleinopathies including Parkinson's disease and dementia with Lewy bodies.Wren possesses a novel network kinetics drug discovery platform that precisely quantifies the effects of small molecules on the protein misfolding and aggregation pathway that causes neurodegenerative diseases. Wren's approach to synucleinopathies is focused on identifying novel small molecules that selectively control the aggregation process of alpha-synuclein, which is associated with the onset and progression of these diseases. The collaboration will use Wren's network kinetics drug discovery platform, alongside Eisai's extensive experience in drug discovery for neurodegenerative disorders, to accelerate the development of clinical candidates.Dr. Samuel Cohen, Chief Executive Officer of Wren, commented: "We are delighted to have formed this collaboration with Eisai, a company with a distinguished track record and company-wide commitment to providing innovative treatments for patients suffering from neurodegenerative diseases. We believe that by combining our unique, predictive and quantitatively driven platform with Eisai's deep expertise in neurology, we can together advance highly differentiated small molecules targeting alpha-synuclein for the treatment of debilitating protein misfolding disorders such as Parkinson's disease."Dr. Teiji Kimura, Vice President, Chief Discovery Officer of the Eisai Neurology Business Group, commented: "Synucleinopathies such as dementia with Lewy bodies and Parkinson's disease represent a significant unmet medical need due to the lack of any effective disease-modifying treatments. The accumulation of alpha-synuclein oligomers with protein misfolding is an important hallmark of these diseases. The Wren team, with its world-renowned founding scientists, is pioneering a new and fundamentally different approach to addressing protein misfolding diseases. By integrating capabilities across both companies we expect this exciting collaboration to be uniquely successful in identifying novel disease-modifying therapeutics for patients suffering from dementia with Lewy bodies, Parkinson's disease and related disorders."About Wren's novel network kinetics drug discovery platformWren's proprietary network kinetics drug discovery platform enables an entirely new approach to drug discovery, designed specifically to address the unique challenges associated with protein misfolding diseases. The kinetics-based approach solves for the distinct molecular reaction network that underlies each misfolding disease and produces a fully predictive, quantitative map of the network and its dynamics. The platform identifies the optimum intervention points in the network to reduce the populations of toxic misfolded and aggregated species, and subsequently makes it possible to identify and optimise molecules with the desired kinetics inhibitory activity.About SynucleinopathiesSynucleinopathies are neurodegenerative diseases characterised by the aberrant misfolding and aggregation of alpha-synuclein in neurons and glial cells. Synucleinopathies include Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA).About Eisai Co., Ltd.Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products to address unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology. As a global pharmaceutical company, our mission extends to patients around the world through working with key stakeholders to improve access to medicines in developing and emerging countries.For further information on Eisai Co., Ltd., please visit https://www.eisai.com.About Wren Therapeutics Ltd.Wren is a spin-off company from the University of Cambridge (UK) and Lund University (Sweden), focused on drug discovery and development for protein misfolding diseases. Wren is advancing an entirely novel approach to address this class of diseases, based on more than a decade of research from its scientific founders focused on the chemical kinetics of the protein misfolding process. Wren's predictive, quantitative platform is built on concepts from the physical sciences and is a fundamental shift from the descriptive, qualitative methods of traditional biology, which have failed to successfully address these complex systems. Wren is using its unique approach to develop a broad pipeline of therapeutics for protein misfolding diseases.For further information on Wren, please visit www.wrentherapeutics.com Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Nov 30, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that the company will present the latest data on its in-house discovered and developed anti-epileptic agent (AED) perampanel (product name: Fycompa), at the 74th American Epilepsy Society Annual Meeting (AES2020), to be held virtually from December 4 to 8, 2020.A total of 43 poster presentations regarding perampanel are planned, including analysis results from the phase III clinical trial (FREEDOM/Study 342), which evaluated the effectiveness and safety of the perampanel monotherapy in the open-label extension (52 weeks) for epilepsy patients with partial onset seizures (POS) from 12 to 74 years of age without prior treatment history. Additionally, results from the phase III clinical trial Study 311 evaluating safety and tolerability of perampanel as an adjunctive therapy in pediatric epilepsy patients with POS or primary generalized tonic clonic (PGTC) seizures from 4 to less than 12 years of age will be presented.Perampanel is a first-in-class AED discovered at Eisai's Tsukuba Research Laboratories. The agent is a highly selective, noncompetitive AMPA receptor antagonist that is postulated to reduce neuronal hyper-excitation associated with seizures by targeting glutamate activity at AMPA receptors on postsynaptic membranes. In Japan and the United States, perampanel is currently approved for monotherapy and adjunctive use in the treatment of POS (with or without secondarily generalized seizures) in patients with epilepsy 4 years of age and older, as well as adjunctive treatment for primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older.Eisai considers neurology, including epilepsy, a therapeutic area of focus. As we provide perampanel globally, Eisai pursues its mission to provide "seizure freedom" to a greater number of patients with epilepsy. Eisai seeks to address the diverse needs of, as well as increase the benefits provided to, patients with epilepsy and their families.For more information, visit https://www.eisai.com/news/2020/pdf/enews202080pdf.pdf.About EisaiEisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products to address unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology. As a global pharmaceutical company, our mission extends to patients around the world through our investment and participation in partnership-based initiatives to improve access to medicines in developing and emerging countries.For more information about Eisai Co., Ltd., please visit https://www.eisai.com Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

Toyota City, Japan, Nov 27, 2020 - (JCN Newswire) - Toyota Motor Corporation (TMC) announces its sales, production, and export results for October 2020 as well as the cumulative total from January to October 2020, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd.Global SalesResults in October were driven primarily by sales in the U.S. and China, and global sales were up approximately 8 percent year-on-year.U.S.The market as a whole is trending toward recovery, and sales of the Camry, RAV4, and Lexus brand models were strong, resulting in a new record high for October.ChinaIn addition to measures to attract customers to dealers including regional motor shows, sales of the Corolla, Levin, and Lexus brand models were strong, and as a result, sales were up approximately 33 percent year-on-year, the seventh consecutive year-on-year increase.Global ProductionResults in October were driven primarily by production in China and Japan, and production was up approximately 9 percent year-on-year.ChinaStrong sales of the Levin and Corolla had an impact, and production was up approximately 10 percent year-on-year.JapanIn addition to recovery of the global market, sales in Japan of new models including the Harrier and Yaris were strong, and as a result, production up approximately 12 percent year-on-year.For the full report, visit https://bit.ly/3fIAUlN.About Toyota Motor CorporationToyota Motor Corporation works to develop and manufacture innovative, safe and high-quality products and services that create happiness by providing mobility for all. We believe that true achievement comes from supporting our customers, partners, employees, and the communities in which we operate. Since our founding over 80 years ago in 1937, we have applied our Guiding Principles in pursuit of a safer, greener and more inclusive society. Today, as we transform into a mobility company developing connected, automated, shared and electrified technologies, we also remain true to our Guiding Principles and many of the United Nations' Sustainable Development Goals to help realize an ever-better world, where everyone is free to move.SDGs Initiatives: https://global.toyota/en/sustainability/sdgs/ Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Nov 27, 2020 - (JCN Newswire) - Honda Motor Co., Ltd. has announced that the company was selected for the fourth consecutive year as a component of the Dow Jones Sustainability World Index (DJSI World). The Dow Jones Sustainability Indices (DJSI) serve as one of the key benchmarks for socially responsible investing*.The DJSI are the investment indices run by the U.S.-based S&P Global Inc. who evaluate sustainability of the world's leading companies in terms of economic, environmental and social criteria and select companies that demonstrate overall excellence for the indices.Based on their annual DJSI review, S&P Global Inc. published the components list and Honda was selected as a component of the Dow Jones Sustainability Asia/Pacific Index for six consecutive years. In the review, Honda was also ranked in the top 4 for the global Automobile sector and added to the DJSI World.Honda issued the "Honda SUSTAINABILITY REPORT 2020" summarizing Honda's approach and initiatives to sustainability. For more information, please visit https://global.honda/about/sustainability.html.Through unique creations and challenges as a mobility company, Honda will continue providing appealing products and services that bring joy to customers while listening to stakeholders' voices and helping to solve various social issues. Thus, Honda will strive to become a company society wants to exist.*Investment strategy which includes criteria for evaluating investees' corporate social responsibility, in addition to conventional financial indicator analysisAbout HondaHonda Motor Co., Ltd. (TSE:7267 / NYSE:HMC / LSE:HNDA) is one of the leading manufacturers of automobiles and power products and the largest manufacture of motorcycles in the world. Honda has always sought to provide genuine satisfaction to people worldwide. The result is more than 120 manufacturing facilities in 30 countries worldwide, producing a wide range of products, including motorcycles, ATVs, generators, marine engines, lawn and garden equipment and automobiles that bring the company into contact with over 19 million customers annually. For more information, please visit http://world.honda.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Nov 27, 2020 - (JCN Newswire) - Honda Motor Co., Ltd. today announced a summary of automobile production, Japan domestic sales, and export results for the month of October 2020.World Production- Production in Japan experienced a year-on-year increase for the second consecutive month.- Production in regions outside of Japan experienced a year-on-year increase for the second consecutive month.- Worldwide production experienced a year-on-year increase for the second consecutive month.Sales in the Japanese Market- Total Japanese sales experienced a year-on-year increase for the first time in 13 months.- New vehicle registrations experienced a year-on-year increase for the first time in 13 months.- Sales of mini-vehicles experienced a year-on-year increase for the first time in eight months.- Fit was the industry's seventh best-selling car among new vehicle registrations for the month of October 2020 with sales of 9,000 units. Freed was the industry's eighth best-selling car among new vehicle registrations for the month of October 2020 with sales of 7,849 units.- N-BOX was the industry's top-selling car in the mini-vehicle category for the month of October 2020 with sales of 16,052 units. N-WGN was the industry's nineth best-selling car in the mini-vehicle category for the month of October 2020 with sales of 5,943 units.Exports from Japan- Total exports from Japan experienced a year-on-year decrease for the second consecutive month.For the full press release, visit https://global.honda/newsroom/news/2020/c201127beng.html.About HondaHonda Motor Co., Ltd. (TSE:7267 / NYSE:HMC / LSE:HNDA) is one of the leading manufacturers of automobiles and power products and the largest manufacture of motorcycles in the world. Honda has always sought to provide genuine satisfaction to people worldwide. The result is more than 120 manufacturing facilities in 30 countries worldwide, producing a wide range of products, including motorcycles, ATVs, generators, marine engines, lawn and garden equipment and automobiles that bring the company into contact with over 19 million customers annually. For more information, please visit http://world.honda.com. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Nov 27, 2020 - (JCN Newswire) - AbbVie GK and Eisai Co., Ltd. today announced an approval of additional indication of HUMIRA (generic name: adalimumab [recombinant], hereafter "HUMIRA"), a fully human anti-TNFalpha monoclonal antibody, for the treatment of pyoderma gangrenosum (hereafter "PG"). HUMIRA was granted orphan drug designation for the treatment of PG in 2019. This indication counts for HUMIRA's 12th indication in Japan and makes HUMIRA the world's first drug indicated for the treatment of PG.This approval of the additional indication is based on the data from the Japanese phase III clinical trial(1) conducted in Japanese patients. This study was conducted to evaluate the efficacy and safety of HUMIRA targeting the patients with active ulcers in Japan who were diagnosed with PG but were not sufficiently effective with local treatment, or who were judged to be unsuitable for local treatment. The proportion of patients achieving at 100 (targeted PG ulcer healed) of the target pyoderma gangrenosum ulcer area reduction (PG Area Reduction: PGAR) at Week 26 of administration, which is the primary endpoint of this trial, was 54.5% (12 of 22 patients)1. The most common adverse drug reactions in patients receiving HUMIRA were skin bacterial infection(1).PG is an inflammatory skin disease that rapidly progresses after its onset and is classified into the following 5 types: ulcerative type, bullous type, pustular type, vegetative type, and a type that develops around a stoma(2). In ulcerative PG, the most common type, appears as painful, pustules, papules and nodules in the lower extremities, especially in the lower legs, and efferently expands to form raised ulcer lesions with infiltration on the margins(3). The ulceration accompanied by intense pain and is known to cause serious effects on patients' quality of life (QOL)(4). Although the pathogenic mechanism of PG is not fully understood, it is reported that approximately 20-30% of PG cases are caused by a slight injury or an external stimulus(5). PG mostly affects people in their 50s to 70s, and its incidence is reported to be 3.0 per million/year in Japan(6).AbbVie and Eisai are committed to further contribute to the improvement of QOL of many more patients by making efforts to promote the appropriate use of HUMIRA, including its use for this indication, and to provide information on HUMIRA.(1) ClinicalTrials.gov Identifier: NCT03311464. Unpublished data on file.(2) Yamamoto T: J Dermatol, 130(6), 1439-1448, 2020(3) Idemitsu T. Medical diseases seen in 110 cases of skin symptoms: 7(4), 138-139, 2018(4) Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA Williams HC; UK Dermatology Clinical Trials Network's STOP GAP Team.. 2015 Jun 12; 350: h2958. doi: 10.1136/bmj.h2958.(5) Callen JP, Jackson JM: Pyoderma gangrenosum: an update,　 Rheum Dis Clin North Am, 2007; 33: 787--802.(6) Yamamoto T: J Dermatol, 46: e145-e146, 2019About EisaiEisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products to address unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology. As a global pharmaceutical company, our mission extends to patients around the world through our investment and participation in partnership-based initiatives to improve access to medicines in developing and emerging countries.For more information about Eisai Co., Ltd., please visit https://www.eisai.com Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com

TOKYO, Nov 27, 2020 - (JCN Newswire) - Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a Mitsubishi Heavy Industries (MHI) Group company, is launching a line of single fan and multiple room outdoor unit air conditioners for buildings that use R32 refrigerant. Launched specifically for the European market, the systems will sell through MHI subsidiary Mitsubishi Heavy Industries Air-Conditioning Europe, Ltd. (MHIAE).Available from December 2020, the product lineup will include six models with capacity up to 4, 5, and 5.5 horsepower, each available in either the single-phase alternating current (AC) common in ordinary homes, or the three-phase AC used in factories and other facilities that consume a lot of electricity. As countries throughout the world are shifting to refrigerants with less environmental impact, such as R32. The highly anticipated product lineup will respond to the decline of R410A refrigerant usage, a common option in Europe in the air conditioning market up to now.The series will optimise the company's top-selling model in the European market, the Micro KX series with the R32 refrigerant variant. The latest model will keep its current single fan structure to maintain its small and lightweight size. However, the refrigerant distribution system in the outdoor unit will change to accommodate the material property of R32 refrigerant, and increased performance of the heat exchanger will maximise to further enhance efficiency. Additional innovations include updating the compressor motor from a distributed winding type to a concentrated winding type. The new compressor motor will improve unit performance at an intermediate capacity, and lower standby power consumption from greater efficiency.R32 refrigerant has zero ozone depletion potential (ODP)(1) and one-third of the global warming potential (GWP)(2) of the conventional R410A refrigerant. This sustainable solution has attracted attention for its high heat transfer efficiency, as well as an excellent safety and environmental performance. Measures to prevent climate change have increased worldwide in response to the October 2016 Kigali revision to the Montreal Protocol. The demand to convert existing facilities to R32 refrigerant and other replacements, especially for outdoor multiple-room air conditioners, are prospective to continue in the future.MHI Thermal Systems will focus on its sales and service for air conditioning equipment, including air conditioners for stores and offices, and building air conditioning systems. The company will continue to pursue corporate activities that take into account customer convenience and operability, as well as the global environment.(1) Ozone Depletion Potential (ODP) is a coefficient expressing a relative value, with the widely used refrigerant CFC-11 (trichlorofluoromethane) fixed at an ODP of 1.0. The smaller the number, the less relative amount of degradation to the ozone layer.(2) Global Warming Potential (GWP) is a coefficient expressing a relative value, with CO2 fixed at a GWP of 1.0. The smaller the number, the greater the environmental performance. Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com